PA8602001A1 - PHARMACEUTICAL COMPOUND - Google Patents

PHARMACEUTICAL COMPOUND

Info

Publication number
PA8602001A1
PA8602001A1 PA20048602001A PA8602001A PA8602001A1 PA 8602001 A1 PA8602001 A1 PA 8602001A1 PA 20048602001 A PA20048602001 A PA 20048602001A PA 8602001 A PA8602001 A PA 8602001A PA 8602001 A1 PA8602001 A1 PA 8602001A1
Authority
PA
Panama
Prior art keywords
pharmaceutical compound
same
compound
methybutile
cycllobutilo
Prior art date
Application number
PA20048602001A
Other languages
Spanish (es)
Inventor
Rajendra Narayanrao Kankan
Ramachandra Rao Dharmaraj
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of PA8602001A1 publication Critical patent/PA8602001A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/16—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPUESTO DE SIBUTRAMINA, N-{1-[1-(4- CLOROFENILO) CICLOBUTILO] -3- METIBUTILO} -N,N- DIMETILAMINA (N-{1-[1-(4- CHLOROPHENYL)CYCLOBUTYL)]-3-METHYLBUTYL}-N,N-DIMETHYL-AMINE, REFINADA, EN FORMA CRISTALINA, QUE CONTENGA LO MISMO Y PARA LOS MISMOS USOS.SIBUTRAMINE COMPOUND, N- {1- [1- (4- CHLOROPHENYLL) CYCLLOBUTILO] -3- METHYBUTILE} -N, N- DIMETHYLAMINE (N- {1- [1- (4- CHLOROPHENYL) CYCLOBUTYL)] - 3- METHYLBUTYL} -N, N-DIMETHYL-AMINE, REFINED, IN CRYSTAL FORM, CONTAINING THE SAME AND FOR THE SAME USES.

PA20048602001A 2003-05-06 2004-05-06 PHARMACEUTICAL COMPOUND PA8602001A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310361.1A GB0310361D0 (en) 2003-05-06 2003-05-06 Pharmaceutical compound

Publications (1)

Publication Number Publication Date
PA8602001A1 true PA8602001A1 (en) 2004-11-26

Family

ID=9957512

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20048602001A PA8602001A1 (en) 2003-05-06 2004-05-06 PHARMACEUTICAL COMPOUND

Country Status (7)

Country Link
EP (1) EP1620388A1 (en)
KR (1) KR20060034636A (en)
AR (1) AR046070A1 (en)
CL (1) CL2004000948A1 (en)
GB (1) GB0310361D0 (en)
PA (1) PA8602001A1 (en)
WO (1) WO2004099119A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008526836A (en) * 2005-01-06 2008-07-24 シージェー チェイルジェダン コーポレーション Sibutramine inorganic acid salt
KR100814384B1 (en) * 2006-02-10 2008-03-18 대화제약 주식회사 Pharmaceutical composition containing sibutramine salt, and manufacturing method thereof
KR100806673B1 (en) * 2006-06-23 2008-03-03 주식회사 대희화학 Process for Preparing Crystalline Sibutramine Free Base

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound

Also Published As

Publication number Publication date
EP1620388A1 (en) 2006-02-01
GB0310361D0 (en) 2003-06-11
KR20060034636A (en) 2006-04-24
WO2004099119A1 (en) 2004-11-18
AR046070A1 (en) 2005-11-23
CL2004000948A1 (en) 2005-04-22

Similar Documents

Publication Publication Date Title
UY28348A1 (en) NEW COMPOUNDS
UY27712A1 (en) REPLACED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, MANUFACTURING AND USE PROCEDURES
UY38258A (en) MOLECULES THAT HAVE PESTICIDAL UTILITY, AND COMPOSITIONS AND PROCESSES, RELATED TO THEM
UY28941A1 (en) REPLACED INDAZOLS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURE AND ITS USE
RS50660B (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
UY28342A1 (en) NEW COMPOUNDS
PE20142371A1 (en) PHARMACEUTICAL COMBINATION OF 3- (3-DIMETHYLAMINE-1-ETHYL-2-METHYL-PROPYL) -PHENOL AND AN ANTIEPYLEPTIC
ECSP055708A (en) 4-FLUORO-2-CYANOPIRROLIDINE DERIVATIVES BENCENOSULFONATE
CR7583A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
IL211085A0 (en) Perfusion solution
BRPI0415505A (en) mesothelioma therapeutic agent
DOP2010000134A (en) SOME DERIVATIVES OF 2-PIRAZINONA AS INHIBITORS OF ELASTASA DE LOS NEUTROFILOS
ECSP066481A (en) FORMULATIONS CONTAINING COPPER
BRPI0620229A8 (en) formulation
CY1118976T1 (en) CRYSTAL MODIFICATIONS OF (1R, 2R) -3- (3-DIMETHYLAMINE-1-ETHYL-2-Methyl-propyl) -phenol
PA8577201A1 (en) 3-PHENYL-PROPIONAMIDE, 3-PHENYL-ACRYLAMID AND DERIVATIVES 3-PHENYL-PROPINAMID AS MAO-B INHIBITORS
PA8604401A1 (en) ARIL-HETEROAROMATIC PRODUCTS, COMPOSITIONS THAT CONTAIN THEM AND ITS USE.
DE502004002241D1 (en) DIPOLASTRAYERS, IN PARTICULAR DUAL POLARIZED DIPOLATION EQUIPMENT
AR056067A1 (en) PROCEDURE FOR THE PROTECTION AGAINST PHYTOPATHOGENS BY CHIRALAXIL, CORRESPONDING USE AND AGENTS INTENDED FOR THAT PURPOSE
IS2597B (en) Medicines composed of R, R-formoterol and cyclesonide
ATE417560T1 (en) SURGICAL NAIL
PA8602001A1 (en) PHARMACEUTICAL COMPOUND
ECSP066515A (en) USE OF BASIC AMINO ACIDS IN FUNGICIDED FORMULATIONS CONTAINING COPPER
PL1937062T3 (en) Active substance mixtures comprising opp and amines, microbicidal agents
UY28685A1 (en) HETEROCICLES WITH NITROGEN CONTENT AFFECTING THE SYNTHETIC GLUTAMATERIC TRANSMISSION